Abstracts Archive - Page 1453 of 2425 - ACR Meeting Abstracts

Abstract Number: 528 • 2016 ACR/ARHP Annual Meeting
Assessment of Metacarpal Head Bone Microarchitecture According to Presence or Not of Inflammation in Rheumatoid Arthritis Patients with Low Disease Activity
Shuing Kong¹, Hervé Locrelle¹, Adamah Amouzougan¹, Delphine Denarie¹, Philippe Collet¹, Béatrice Pallot Prades¹, Thierry Thomas^1,2 and Hubert Marotte^1,2, ¹Rheumatology Department, University Hospital of Saint-Etienne, Saint-Etienne, France, ²INSERM U1059/LBTO, Université de Lyon - Université Jean Monnet, Saint-Etienne, France
Background/Purpose: Bone alteration at the metacarpeal head during rheumatoid arthritis (RA) disease remained under investigated. High‐resolution peripheral quantitative computed tomography (HRpQCT) allows exploration of microarchitecture…
Abstract Number: 529 • 2016 ACR/ARHP Annual Meeting
The Relationship Between Promis and CDAI Scores, Disease Duration, Age and Gender in Patients with Rheumatoid Arthritis
Alicia Lieberman¹, Judith Baumhauer², Chris Dasilva² and Allen P. Anandarajah³, ¹Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, ²Orthopedic surgery, University of Rochester Medical Center, Rochester, NY, ³Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY
Background/Purpose: PROMIS (Patient-Reported Outcomes Measurement Information System) is a self-reported and parent-reported measure of global, physical, mental, and social health for the general population…
Abstract Number: 530 • 2016 ACR/ARHP Annual Meeting
Importance of Functional and Utility Evaluation on Disease Activity Level in Rheumatoid Arthritis: Interrelations and Predictive Value
Corina Mogosan¹, Catalin Codreanu¹, Luminita Enache¹, Magda Parvu², Simona Rednic³, Ruxandra Ionescu⁴ and On behalf of the Romanian Registry of Rheumatic Diseases, ¹Rheumatology, 'Dr. Ion Stoia' Clinical Center of Rheumatic Diseases, Bucharest, Romania, ²Rheumatology, Colentina Hospital, Bucharest, Romania, ³Rheumatology, Emergency County Clinical Hospital Cluj Napoca, Cluj-Napoca, Romania, ⁴Rheumatology, Sfanta Maria Clinical Hospital, UMF Carol Davila, Bucharest, Romania
Background/Purpose: Rheumatoid Arthritis (RA) treatment targets remission or low disease activity, thus reducing the disease impact in patients’ lives. Assessing different tools for effectiveness (disease…
Abstract Number: 531 • 2016 ACR/ARHP Annual Meeting
Disease Activity and Physical Fatigue As Related to Adherence and Health Literacy in Patients with Rheumatoid Arthritis
Jens Gert Kuipers¹, Michael Koller², Florian Zeman², Karolina Mueller³ and Ulrich Rueffer⁴, ¹Department of Rheumatology, Red Cross Hospital Bremen, Bremen, Germany, ²Center of Clinical Studies, University Hospital Regensburg, Regensburg, Germany, ³Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany, ⁴German Fatigue Society, Cologne, Germany
Disease activity and physical fatigue as related to adherence and health literacy in patients with rheumatoid arthritis J. G. Kuipers1, M. Koller2, F. Zeman2, K.…
Abstract Number: 532 • 2016 ACR/ARHP Annual Meeting
The DAS28 Score May Misread Disease Activity in Rheumatoid Arthritis Patients
Abdul Khan¹ and Apostolos Vrettos², ¹Rheumatology, East Kent University Hospital NHS Foundation Trust, Queen Elizabeth Queen Mother Hospital, Margate, United Kingdom, ²Rheumatology, Queen Elizabeth Queen Mother Hospital, Margate, United Kingdom
Background/Purpose: The DAS28 is a measure of disease activity in rheumatoid arthritis (RA). DAS28 stands for 'disease activity score' and the number 28 refers to…
Abstract Number: 533 • 2016 ACR/ARHP Annual Meeting
What Proportion of Patients Fail to Achieve CDAI and SDAI Remission Based on Physician Global Assessment? an Analysis from the Prospective, Observational Registry
Michael Starr¹, Boulos Haraoui², Denis Choquette³, Louis Bessette⁴, Andrew Chow⁵, Philip Baer⁶, Suneil Kapur⁷, John Kelsall⁸, Michelle Teo⁹, Emmanouil Rampakakis¹⁰, Eliofotisti Psaradellis¹¹, Francois Nantel¹², Allen J Lehman¹³, Brendan Osborne¹⁴, Karina Maslova¹³ and Cathy Tkaczyk¹⁴, ¹Rheumatology, Mcgill University, Pointe-Claire,, QC, Canada, ²University of Montreal, Montreal, QC, Canada, ³Rheumatology, Institut de Recherche en Rhumatologie de Montréal (IRRM), Montréal, QC, Canada, ⁴Rheumatology, CHUL de Quebec, Quebec, QC, Canada, ⁵Credit Valley Rheumatology, Mississauga, ON, Canada, ⁶Independent Rheumatology Practice, Scarborough, ON, Canada, ⁷University of Ottawa, 139 Greenbank Rd, Suite 203, ON, Canada, ⁸Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada, ⁹Balfour Medical Clinic, Penticton, BC, Canada, ¹⁰JSS Medical Research, St-Laurent, QC, Canada, ¹¹JSS Medical Research, Montreal, QC, Canada, ¹²19 Green belt Dr, Janssen Inc., Toronto, ON, Canada, ¹³Janssen Inc., Toronto, ON, Canada, ¹⁴Medical Affairs, Janssen Inc., Toronto, ON, Canada
Background/Purpose: Physician’s Global Assessment of Disease Activity (MDGA) is a measure that is frequently incorporated in disease activity indices which reflects the physician’s perception of…
Abstract Number: 534 • 2016 ACR/ARHP Annual Meeting
Discordance Between Physician-Stated Remission and 28-Joint Disease Activity Score (DAS28)-Defined Remission in Rheumatoid Arthritis Patients
Nan Li¹, Stuart Blackburn², Emma Sullivan², Danuta Kielar¹ and Steve Peterson¹, ¹Janssen Research & Development, LLC, Spring House, PA, ²Adelphi Real World, Manchester, United Kingdom
Background/Purpose: Data were drawn from the 2014 Adelphi RA Disease Specific Programme in 5 European countries (France, Germany, Italy, Spain, UK). Rheumatologists provided details about…
Abstract Number: 535 • 2016 ACR/ARHP Annual Meeting
Examination of Diurnal and Daily Variation of the Multi-Biomarker Disease Activity (MBDA) Score in RA to Establish the Minimally Important Difference
David Chernoff¹, Rebecca J. Bolce¹, Ching Chang Hwang², Xingbin Wang¹, Alan Kivitz³ and Jeffrey R. Curtis⁴, ¹Crescendo Bioscience Inc., South San Francisco, CA, ²Biostatistics, Crescendo Bioscience Inc., South San Francisco, CA, ³Altoona Center for Clinical Research, Duncansville, PA, ⁴Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The biological variability in MBDA scores over a 24-hour period and day-to-day in patients with rheumatoid arthritis (RA) has not been well characterized. These…
Abstract Number: 536 • 2016 ACR/ARHP Annual Meeting
Precision Medicine in Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis on the Diagnostic Accuracy of Anti-CCP Tests for the Diagnosis of Rheumatoid Arthritis
Gaia Gallo¹, Barbara Mascialino¹, Donna Fountain², Kevin Cadwell² and Sigrid Sjolander¹, ¹Immuno Diagnostics, Thermo Fisher Scientific, Uppsala, Sweden, Uppsala, Sweden, ²PHMR, Berkeley Works, Berkley Grove, London, London, United Kingdom
Background/Purpose: Biological markers are objective molecular indicators possessing diagnostic, prognostic and predictive utility. The detection of antibodies to cyclic citrullinated peptides (Anti-CCP) may occur long…
Abstract Number: 537 • 2016 ACR/ARHP Annual Meeting
Differences and Associated Factors in General Disability and Hand Disability Between Patients with Rheumatoid Arthritis and Psoriatic Arthritis
Jose Andres Roman Ivorra¹, Óscar Álvarez¹, Jose Ivorra Cortes¹, Javier Navarro Muñoz², Elena Grau Garcia³, Luis Gonzalez Puig¹, Inmaculada Chalmeta Verdejo¹, Carlos Feced Olmos¹, Eztizen Labrador Sanchez¹, Francisco Miguel Ortiz-Sanjuán⁴, Karla Arevalo Ruales¹, Rosa Negueroles Albuixech¹, Jorge Fragio Gil¹, Isabel Martinez Cordellat¹, Jose Luis Valero Sanz¹, Cristina Alcañiz Escandell^1,3, Gema Poveda Marin^1,3, Carmen Najera Herranz¹ and Victoria Fornes Ferrer⁵, ¹Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²Universidad Católica de Valencia, Valencia, Spain, ³IIS La Fe, Valencia, Spain, ⁴Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Santander, Spain, ⁵Biostatistics Unit. IIS La Fe, Valencia, Spain
Background/Purpose: Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are well-known disabling conditions, with high impact on patients functioning and quality of life. However, little is…
Abstract Number: 538 • 2016 ACR/ARHP Annual Meeting
What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis?
Matthew A. Jessome¹, Karen A. Beattie², William G. Bensen², Raja S. Bobba², Alfred Cividino², Patrick D. Emond², Chris Gordon², Lawrence Hart², George Ioannidis², Maggie Larche², Arthur Lau³, Ruben Tavares², Stephen Tytus² and Jonathan D. Adachi², ¹Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada, ²St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, ³50 Charlton Avenue East, St Joseph's Healthcare Hamilton, Hamilton, ON, Canada
Background/Purpose: Erosive damage to small joints is a hallmark feature of rheumatoid arthritis (RA). The degree to which early erosive damage contributes to joint pain…
Abstract Number: 539 • 2016 ACR/ARHP Annual Meeting
Promis Short Forms Are Relevant to People Living with RA: Results of Cognitive Debriefing Interviews
Anna Kristina Gutierrez¹, Susan J. Bartlett^1,2, Alessandra Butanis³, Vivian P. Bykerk⁴, Jeffrey R. Curtis⁵, Amye L. Leong⁶, Anne Lyddiatt⁷ and Clifton Bingham III⁸, ¹Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, ³Johns Hopkins University School of Medicine, Baltimore, MD, ⁴Divison of Rheumatology, Hospital for Special Surgery, New York, NY, ⁵Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁶Strategic Relations, Bone & Joint Decade, Santa Barbara, CA, ⁷Musculoskeletal Group, Cochrane Collaboration, Hamilton, ON, Canada, ⁸Johns Hopkins University, Baltimore, MD
Background/Purpose: PROMIS® measures were developed to assess physical, mental, and social health across chronic diseases and include brief short forms (SFs; 4-8 items) to assess…
Abstract Number: 540 • 2016 ACR/ARHP Annual Meeting
The Importance of Outcome Measures in Rheumatoid Arthritis – Validity of the Routine Assessment of Patient Index Data 3 in a Real World Setting
Sergio Schwartzman¹, Keith Knapp^2,3, Gary Craig^2,3, Karen Ferguson^2,3 and Discus Analytics, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Arthritis Northwest PLLC., Spokane, WA, ³Discus Analytics LLC., Spokane, WA
The Importance of Outcome Measures in Rheumatoid Arthritis - Validity of the RAPID3 (Routine Assessment of Patient Index Data 3) in a United States “Real…
Abstract Number: 541 • 2016 ACR/ARHP Annual Meeting
Patient Goals in Rheumatoid Arthritis Care: A Literature Review
Elizabeth Hulen¹, Ayla Ervin¹, Allison Schue¹, Gina Evans-Young², Somnath Saha^3,4, Edward H. Yelin⁵ and Jennifer Barton^1,4, ¹VA Portland Health Care System, Portland, OR, ²Rheumatology, UCSF, San Francisco, CA, ³Medicine, VA Portland Health Care System, Portland, OR, ⁴Oregon Health & Science University, Portland, OR, ⁵Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: While clinician goals when treating rheumatoid arthritis (RA) focus on achieving low disease activity or remission, RA patient goals remain largely unexplored. Patient-clinician goal…
Abstract Number: 542 • 2016 ACR/ARHP Annual Meeting
Changes on Body Composition in Women with Long-Standing Established Rheumatoid Arthritis: Differences By Level of Disease Activity
Gabriela Daffre Carvalho¹, Karina Bonfiglioli², Ana C. M. Ribeiro¹, Celio R. Gonçalves¹, Rosa M R Pereira³ and Diogo S Domiciano⁴, ¹Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, ³Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, ⁴Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Studies on association between inflammatory activity and body composition changes in rheumatoid arthritis (RA) are controversial due to some limitations: use of low accuracy…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].